New half sandwich Ru(II) coordination compounds for anticancer activity.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Dalton Transactions

• Publication date

  2012-05-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1039/c2dt30654aPMID 22580919
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New half sandwich-type Ru(II) coordination compounds characterized by the fac-Ru(dmso-S)3 fragment: influence of the face-capping group on the chemical behavior and in vitro anticancer activity.

  2011cited by this paper
• Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs.

  2011cited by this paper
• Arene ruthenium complexes as anticancer agents.

  2010cited by this paper
• Organometallic Anticancer Compounds

  2010cited by this paper
• Synthesis, molecular structure and evaluation of new organometallic ruthenium anticancer agents.

  2009cited by this paper
• Recent developments in ruthenium anticancer drugs.

  2009cited by this paper
• Inert ruthenium half-sandwich complexes with anticancer activity.

  2009cited by this paper
• Synthesis, X-ray diffraction structure, spectroscopic properties and antiproliferative activity of a novel ruthenium complex with constitutional similarity to cisplatin.

  2009cited by this paper
• A glycine ruthenium trithiacyclononane complex and its molecular encapsulation using cyclodextrins.

  2009cited by this paper
• Oxygen Evolution from Water Catalyzed by Mononuclear Ruthenium Complexes with a Triazamacrocyclic Ligand in a Facial Fashion

  2009cited by this paper
• Medicinal organometallic chemistry: designing metal arene complexes as anticancer agents.

  2008cited by this paper
• Molecular architectures for trimetallic d/f/d complexes: structural and magnetic properties of a LnNi2 core.

  2008cited by this paper
• Modulation of the metastatic progression of breast cancer with an organometallic ruthenium compound.

  2008cited by this paper
• A short history of SHELX.

  2008cited by this paper
• Influence of the Diketonato Ligand on the Cytotoxicities of [Ru(η6-p-cymene)(R2acac)(PTA)]+ Complexes (PTA = 1,3,5-triaza-7-phosphaadamantane)

  2008cited by this paper
• Half-sandwich Ru II[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds: preparation, structural characterization and in vitro cytotoxic activity.

  2008cited by this paper
• The design of organometallic ruthenium arene anticancer agents

  2007cited by this paper
• Systematic Design of a Targeted Organometallic Antitumour Drug in Pre-clinical Development

  2007cited by this paper
• Influence of the Polypyridyl (pp) Ligand Size on the DNA Binding Properties, Cytotoxicity and Cellular Uptake of Organoruthenium(II) Complexes of the Type [(η6‐C6Me6)Ru(L)(pp)]n+ [L = Cl, n = 1; L = (NH2)2CS, n = 2]

  2007cited by this paper
• An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells.

  2007cited by this paper
• Half-sandwich RuII-[9]aneS3 complexes with dicarboxylate ligands: synthesis, characterization and chemical behavior.

  2007cited by this paper
• In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes.

  2005cited by this paper
• Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes.

  2005cited by this paper
• Is the Aromatic Fragment of Piano‐Stool Ruthenium Compounds an Essential Feature for Anticancer Activity? The Development of New RuII‐[9]aneS3 Analogues

  2005cited by this paper
• Synthesis and Structural and Spectroscopic Characterization of New RuII-dmso Precursors with Face-Capping Ligands for Use in Self-Assembly Reactions

  2005cited by this paper
• Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: novel recognition mechanisms.

  2003cited by this paper
• In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer

  2002cited by this paper
• Inhibition of cancer cell growth by ruthenium(II) arene complexes.

  2001cited by this paper
• WinGX suite for small-molecule single-crystal crystallography

  1999cited by this paper
• [20] Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• Synthesis, properties and crystal structures of [RuIII2(tacn)2(µ-OH)2(µ-CO3)]Br2·3.75H2O and [Ru3.52(dtne)(µ-O)2(µ-CO3)]PF6·5H2O [tacn = 1,4,7-triazacyclononane, dtne = 1,2-bis(1,4,7-triazacyclononan-1-yl)ethane]

  1994cited by this paper
• Structure and reactions of the thioether half-sandwich ruthenium(II) complexes [Ru(MeCN)3([9]aneS3)][CF3SO3]2 and [Ru(MeCN)2(PPh3)([9]aneS3)][CF3SO3]2([9]aneS3= 1,4,7-trithiacyclononane)

  1994cited by this paper
• Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

  1988cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper

• Unravelling the kinetics of electro- and photochemical S → O linkage isomerization in Ru(II)-NHC-DMSO complexes utilised for photoinduced substitution reactions.

  2024cites this paper
• Half‐sandwich ruthenium complex with a very low overpotential and excellent activity for water oxidation under acidic conditions

  2021cites this paper
• Dual utility of a single diphosphine–ruthenium complex: a precursor for new complexes and, a pre-catalyst for transfer-hydrogenation and Oppenauer oxidation

  2021cites this paper
• Reactivity of N-Heterocyclic Carbene Half-Sandwich Ru-, Os-, Rh-, and Ir-Based Complexes with Cysteine and Selenocysteine: A Computational Study.

  2021cites this paper
• High-resolution crystal structures of a “half sandwich”-type Ru(II) coordination compound bound to hen egg-white lysozyme and proteinase K

  2020cites this paper
• Anticancer activity of benzoxazole derivative (2015 onwards): a review

  2020cites this paper
• Ligand photodissociation in Ru(ii)–1,4,7-triazacyclononane complexes enhances water oxidation and enables electrochemical generation of surface active species

  2020cites this paper
• Ru(ii)-Peptide bioconjugates with the cppH linker (cppH = 2-(2'-pyridyl)pyrimidine-4-carboxylic acid): synthesis, structural characterization, and different stereochemical features between organic and aqueous solvents.

  2019cites this paper
• Synthesis, characterisation, molecular docking, biomolecular interaction and cytotoxicity studies of novel ruthenium(ii)–arene-2-heteroarylbenzoxazole complexes

  2019cites this paper
• Chemistry and reactivity of ruthenium(II) complexes: DNA/protein binding mode and anticancer activity are related to the complex structure

  2019cites this paper
• 1 ( Pyrazolyl ) pyridine ruthenium ( III ) complexes : Synthesis , kinetics of substitution reactions with thiourea and biological studies

  2019cites this paper
• The Pivotal Role of Ru-dmso Compounds in the Discovery of Well-Behaved Precursors

  2018cites this paper
• Amberlite IR-120 (H) mediated "on water" synthesis of fluorescent Ruthenium(II)-arene 8-hydroxyquinoline complexes for cancer therapy and live cell imaging.

  2018cites this paper
• Organoruthenium Prodrugs as a New Class of Cholinesterase and Glutathione‐S‐Transferase Inhibitors

  2018cites this paper
• (Pyrazolyl)pyridine ruthenium(III) complexes: Synthesis, kinetics of substitution reactions with thiourea and biological studies

  2018cites this paper
• Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.

  2017cites this paper
• Inhibition of the Ras/Raf interaction and repression of renal cancer xenografts in vivo by an enantiomeric iridium(iii) metal-based compound

  2017cites this paper
• Small differences in structure, a large difference in activity – Comparing a new Ru(II)-3-hydroxyiminoflavanone complex with analogous Ru(II) compounds

  2017cites this paper
• New 4'-(4-chlorophenyl)-2,2':6',2″-terpyridine ruthenium(II) complexes: Synthesis, characterization, interaction with DNA/BSA and cytotoxicity studies.

  2017cites this paper
• Effect of solvent coordination on the structure of β‐diketone‐based vanadyl complexes and assessment of in vitro antidiabetic activity and cytotoxicity

  2017cites this paper
• Pyrithione-based ruthenium complexes as inhibitors of aldo-keto reductase 1C enzymes and anticancer agents.

  2016cites this paper
• DNA binding properties, histidine interaction and cytotoxicity studies of water soluble ruthenium(ii) terpyridine complexes.

  2016cites this paper
• Anticancer, biophysical and computational investigations of half-sandwich ruthenium(II) thiosemicarbazone complexes: The effect of arene versus thiacrown face-cap

  2016cites this paper
• Amberlite IR-120(H)-mediated “on water” synthesis of novel anticancer ruthenium(II)–p-cymene 2-pyridinylbenzothiazole (BTZ), 2-pyridinylbenzoxazole (BOZ) & 2-pyridinylbenzimidazole (BIZ) scaffolds

  2016cites this paper
• Synthesis of novel anticancer ruthenium-arene pyridinylmethylene scaffolds via three-component reaction.

  2016cites this paper
• Mechanism of the reactions of ruthenium(II) polypyridyl complexes with thiourea, sulfur-containing amino acids and nitrogen-containing heterocycles

  2015cites this paper
• Metal coordination study at Ag and Cd sites in crown thioether complexes through DFT calculations and hyperfine parameters

  2015cites this paper
• Ruthenium complexes as inhibitors of 15-lipoxygenase-1

  2015cites this paper
• Ruthenium complexes as inhibitors of the aldo-keto reductases AKR1C1-1C3.

  2015cites this paper
• Syntheses, crystal structures and antimicrobial activities of Cu(II), Ru(II), and Pt(II) compounds with an anthracene-containing tripodal ligand

  2015cites this paper
• Publications, Patents, Invited Lectures

  2015cites this paper
• Strong in Vitro Cytotoxic Potential of New Ruthenium–Cymene Complexes

  2015cites this paper
• Development of ruthenium-based complexes as anticancer agents: toward a rational design of alternative receptor targets

  2015cites this paper
• Copper(II) and platinum(II) compounds with pyrene-appended dipicolylamine ligand: syntheses, crystal structures and biological evaluation

  2015cites this paper
• Mitigating UVA light induced reactivity of 6-thioguanine through formation of a Ru(II) half-sandwich complex

  2014cites this paper
• Ruthenium(II)–arene complexes with substituted picolinato ligands: Synthesis, structure, spectroscopic properties and antiproliferative activity

  2014cites this paper
• Synthesis, Structure, and Reactivity of Mixed-Ligand Dinuclear Ruthenium Polyhydrido Complexes Supported by 1,4,7-Trimethyl-1,4,7-triazacyclononane and Bulky Phosphine Ligands

  2014cites this paper
• Ru(II) trithiacyclononane 5-(2-hydroxyphenyl)-3-[(4-methoxystyryl)pyrazole], a complex with facile synthesis and high cytotoxicity against PC-3 and MDA-MB-231 cells

  2014cites this paper
• New water-soluble ruthenium(II) terpyridine complexes for anticancer activity: synthesis, characterization, activation kinetics, and interaction with guanine derivatives.

  2014cites this paper
• cis-1,3,5-Triaminocyclohexane as a facially capping ligand for ruthenium(II).

  2013cites this paper
• DNA binding, antitumor activities, and hydroxyl radical scavenging properties of novel oxovanadium(IV) complexes with substituted isoniazid

  2013cites this paper
• Photolabile RuII Half-Sandwich Complexes Suitable for Developing “Caged” Compounds: Chemical Investigation and Unexpected Dinuclear Species with Bridging Diamine Ligands

  2013cites this paper
• Cytotoxicity, apoptosis, cell cycle arrest, reactive oxygen species, mitochondrial membrane potential, and Western blotting analysis of ruthenium(II) complexes

  2013cites this paper
• Ruthenium Compounds as Antitumor Agents: New Developments

  2013cites this paper
• New uses for old drugs: attempts to convert quinolone antibacterials into potential anticancer agents containing ruthenium.

  2013cites this paper
• Design of photoactivatable metallodrugs: Selective and rapid light-induced ligand dissociation from half-sandwich [Ru([9]aneS3)(N–N′)(py)]2+ complexes

  2012cites this paper
• Factors that influence the antiproliferative activity of half sandwich Ru(II)-[9]aneS3 coordination compounds: activation kinetics and interaction with guanine derivatives.

  2012cites this paper
• Anticancer, Biophysical and Computational Investigations of Half-Anticancer, Biophysical and Computational Investigations of Half-Sandwich Ruthenium(II) Thiosemicarbazone Complexes: The Sandwich Ruthenium(II) Thiosemicarbazone Complexes: The Effect of Arene Effect of Arene VersusVersus Thiacrown Fac

  year unknowncites this paper